Reading this news just further highlights that it’s not a good time to be a CEO or Shareholder of company in the very early stages of developing old chemotherapy drugs. Especially when you’ve wasted your days slagging off at other serious cancer companies on social media.
A world of pain coming their way. But they have contributed to our good fortune to be able to load up at .012 cents.
Im really happy with my pile getting even bigger.
Those posters who keep posting their complaints about the company not giving updates on the trials also helped.
Maybe if they had given the minimum amount of research they’d understand the update will come when the data is cut and analysed. That’s how it works.
Clues are everywhere that it is all going well. FDA meeting later this year is one strong indication that alls well!
IMU Price at posting:
1.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)